| Sign In to gain access to subscriptions and/or personal tools. |
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from IranDepartment of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Medical Education Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Department of Neurology and Sina MS Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
Department of Neurology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Department of Anatomy, Neuroscience lab II, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Department of Radiology, Islamic Azad University of Najafabad, Isfahan, Iran
Isfahan Neuroscience Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran; Neuroimmunology unit, Neuroscience Center, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UKMaghzi{at}edc.mui.ac.ir Introduction Co-occurrence of multiple sclerosis (MS) and neurofibromatosis type 1 (NF1) is rare. Case reports In this study, we describe the clinical and neuroimaging features of seven patients with NF1 and MS. In our patients, six patients with MS were women, in all of them history of NF1 existed. Three of our patients had primary progressive, one had secondary progressive MS, and three relapsing–remitting MS. Optic neuritis as presenting symptoms was seen in three patients, and motor manifestation as presenting symptom was observed in three patients. The risk of having both NF1 and MS seemed to be higher than would be expected based on the prevalence rates of the two diseases in the general population. Conclusion The findings of this study suggest a possible casual relationship between MS and NF1, indicating higher risk of MS among patients with NF1.
Key Words: autoimmune Iran multiple sclerosis neurofibromatosis
Multiple Sclerosis, Vol. 15, No. 9,
1126-1130 (2009) |
||||